A Study to Evaluate the Diagnostic Efficacy of DaTSCAN ™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
Conditions: Parkinsonian Syndrome; Parkinson Disease(PD); Multiple System Atrophy (MSA); Progressive Supranuclear Palsy (PSP) Intervention: Drug: DaTSCAN™ Ioflupane (123I) Injection Sponsors: GE Healthcare; PPD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials